EdiTy Therapeutics
Ofer is an expert in tumor immunology and has gained a strong industrial experience Compugen focusing on target validation of immuno-oncology programmes.
EdiTy Therapeutics
EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.